Intraocular shunt implantation
US11298264B2 · kind B2 · utility
0Cited by
187References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 11, 2019 |
| Grant date | Apr 12, 2022 |
| Priority date | — |
| Expiry date | Jun 11, 2040 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61F9/00781
- WIPO fieldMedical technology
- WIPO sectorInstruments
Abstract
Glaucoma can be treated by implanting an intraocular shunt in the eye. The implantation can be performed by first determining an entry area below a corneal limbus of an eye. Thereafter, the intraocular shunt can be inserted into eye tissue through the entry area such that an inflow end of the shunt is positioned in the anterior chamber of the eye and an outflow end of the shunt is positioned between layers of Tenon's capsule.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.